LitAlert ~~

    • New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer.
    • Han Y, Yu X, Li S, Tian Y, Liu C.
    • Front Oncol. 2020 Nov 25;10:578095. doi: 10.3389/fonc.2020.578095.
    • Insights into the impacts of BRCA mutations on clinicopathology and management of early-onset triple-negative breast cancer.
    • Ye F, He M, Huang L, Lang G, Hu X, Shao Z, Di G, Cao A.
    • Front Oncol. 2020 Nov 24;10:574813. doi: 10.3389/fonc.2020.574813.